Beneficiaries of negotiated reimbursement drugs
China, January 2018 – October 2024 to as of 31 Oct 2024
830 million person-visits
as of 31 Oct 2024
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024. 2 observations from January 2018 – October 2024 to as of 31 Oct 2024, ranging from 830 million person-visits to 830 million person-visits. Latest value 830 million person-visits (as of 31 Oct 2024).
million person-visits
0
200
400
600
800
1,000
2018
2019
2020
2021
2022
2023
2024
830
830
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024. 2 observations from January 2018 – October 2024 to as of 31 Oct 2024, ranging from 830 million person-visits to 830 million person-visits. Latest value 830 million person-visits (as of 31 Oct 2024).
million person-visits
0
300
600
900
2018
2019
2020
2021
2022
2023
2024
830
830
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024. 2 observations from January 2018 – October 2024 to as of 31 Oct 2024, ranging from 830 million person-visits to 830 million person-visits. Latest value 830 million person-visits (as of 31 Oct 2024).
million person-visits
0
300
600
900
2018
2019
2020
2021
2022
2023
2024
830
830
View the underlying data
Beneficiaries of negotiated reimbursement drugs: China, January 2018 – October 2024 to as of 31 Oct 2024
Period
Type
Value
January 2018 – October 2024
Actual
830 million person-visits
as of 31 Oct 2024
Actual
830 million person-visits
Chart:
StatOrigin
· Source: State Council, NHSA ·
statorigin.org
CC BY 4.0